Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,537,645
+$3,319,636 QoQ
Shares Held
115,512
+91.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#207
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $116,130,341 across 15 Drug Manufacturers - General names. NVO ranks #8 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,147 | $24,164,918 | |
| 2 | JNJ |
Johnson & Johnson
|
77,048 | $19,567,880 | |
| 3 | ABBV |
AbbVie Inc.
|
56,848 | $14,305,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
88,627 | $11,388,569 | |
| 5 | AZN |
Astrazeneca PLC
|
50,534 | $9,582,257 | |
| 6 | NVS |
Novartis AG
|
61,000 | $9,559,920 | |
| 7 | AMGN |
Amgen Inc
|
16,658 | $6,032,194 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
115,512 | $5,537,645 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,537,645 | 115,512 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,218,009 | 60,354 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,817,471 | 94,683 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,680,137 | 84,342 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,314,011 | 120,458 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,486,812 | 107,817 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,044,505 | 35,393 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,548,354 | 38,199 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,309,214 | 37,195 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,628,178 | 36,045 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,624,474 | 35,036 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,972,737 | 32,689 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,412,237 | 14,906 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,408,583 | 15,135 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,898,143 | 14,025 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,254,740 | 12,594 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,380,283 | 12,387 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,266,192 | 11,402 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,182,496 | 10,558 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $910,558 | 9,484 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $772,275 | 9,219 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $584,733 | 8,673 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $528,066 | 7,560 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $483,093 | 6,958 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $368,390 | 5,626 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,549,108 | 25,733 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||